FDA.reportPublic FDA data

SODIUM HYDROXIDE

Substance profile for UNII 55X04QC32I, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for SODIUM HYDROXIDE
Structure render from PubChem CID 14798

Substance Identity#

UNII
55X04QC32I
Preferred term
SODIUM HYDROXIDE
Registry number
1310-73-2
EC number
215-185-5
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Na.HO
Chemical structure for SODIUM HYDROXIDE
Structure render from PubChem CID 14798

Chemical And Database Identifiers#

InChIKey
HEMHJVSKTPXQMS-UHFFFAOYSA-M
SMILES
[OH-].[Na+]
RxCUI
9880
PubChem
14798
NCIt
C74373
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound14798pubchem.ncbi.nlm.nih.gov/compound/14798
PubChem InChIKey SearchHEMHJVSKTPXQMS-UHFFFAOYSA-Mpubchem.ncbi.nlm.nih.gov/#query=HEMHJVSKTPXQMS-UHFFFAOYSA-M
RxNorm9880mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=9880
NCI ThesaurusC74373ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74373
FDA Substance Registration System55X04QC32Iprecision.fda.gov/uniisearch/srs/unii/55X04QC32I
European Community number215-185-5commonchemistry.cas.org/results?q=215-185-5

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
INACTIVE INGREDIENTf6113982-e3b7-4f42-ae6f-65374f00c7fa8
INACTIVE INGREDIENT11b2f885-b837-455c-8d77-0b38e14e35c37
INACTIVE INGREDIENTThese highlights do not include all the information needed to use duloxetine delayed-release capsules, USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules, USP. DULOXETINE delayed-release capsules USP, for oral use. Initial U.S. Approval: 20047
INACTIVE INGREDIENT3bc870c2-e1db-44ca-9552-ea5981fd3c3310
INACTIVE INGREDIENT2912a0e7-6bcf-4b08-b67e-6a271e8ae31111
INACTIVE INGREDIENTcbd3b7dc-da04-4497-be3c-b94363d6876f20
INACTIVE INGREDIENT8dd7ab8f-2cb0-4600-9f57-ab5cef17155910
INACTIVE INGREDIENT0d52ee7d-a955-4263-b53b-b697c3fa013d8
INACTIVE INGREDIENT9665e134-2343-493d-9bbe-7b3dc577eb017
INACTIVE INGREDIENTEmergency Zit Stick Treatment7
INACTIVE INGREDIENT6fdff658-fd36-44a2-8955-a805369601317
INACTIVE INGREDIENT02d41467-ffed-40f6-ac2a-4c4266557e3d7
INACTIVE INGREDIENTafad39b6-b0a1-48a9-b26b-0602bfc121be7
INACTIVE INGREDIENT98b0ca9a-719f-4e1e-ade6-c80a4455a5b37
INACTIVE INGREDIENT0222f7ec-86ae-474d-ae9a-8ca1b98938a312
INACTIVE INGREDIENTActive Ingredients7
INACTIVE INGREDIENTcdc7af8a-2c09-43e5-b873-cf3eb576c2128
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Cleviprex safely and effectively. See full prescribing information for Cleviprex. Cleviprex (clevidipine) injectable emulsion, for intravenous use Initial U.S. Approval: 200812
INACTIVE INGREDIENTAspirin EC 81 mg17
INACTIVE INGREDIENTThese highlights do not include all the information needed to use AZITHROMYCIN safely and effectively. See full prescribing information for AZITHROMYCIN. AZITHROMYCIN for IV infusion only Initial U.S. Approval: 19917
INACTIVE INGREDIENT253fdee7-5060-4b49-ad26-257eb54cccfa7
INACTIVE INGREDIENTPleasure Balm10
INACTIVE INGREDIENTThese highlights do not include all the information needed to use FORTICAL ® safely and effectively. See full prescribing information for FORTICAL. FORTICAL ® (calcitonin-salmon [rDNA origin]) Nasal Spray for intranasal use Initial U.S. Approval: 200510
INACTIVE INGREDIENT2026988d-7dfa-49ac-bd64-4c2bba197c397
INACTIVE INGREDIENTcb93958f-5c64-4aae-89f1-d5b5048baf6f8
INACTIVE INGREDIENTea4d9094-1aca-4c0f-a67d-7276a9fd591b9
INACTIVE INGREDIENTca1ef1af-714b-4b0b-b816-c6ce12b4c8658
INACTIVE INGREDIENT41717ae2-b729-4970-b32a-8c2ada32e5b98
INACTIVE INGREDIENTf0e3d80e-7cd9-4391-bc65-5d210cc704d87
INACTIVE INGREDIENT985d0bdb-2a45-43a7-9267-6504d76de39c7
INACTIVE INGREDIENT142ec9e6-30dc-4bff-b0c0-d3864c5c1e6f7
INACTIVE INGREDIENTNeova DNA Damage Control - Silc Sheer SPF 40 - Drug Facts7
INACTIVE INGREDIENTb49dcf3f-14d1-4a8b-94c7-e7f4de5d282e7
INACTIVE INGREDIENTThese highlights do not include all the information needed to use epirubicin hydrochloride injection safely and effectively. See full prescribing information for epirubicin hydrochloride injection. EPIRUBICIN Hydrochloride Injection for intravenous use Initial U.S. Approval: 199912
INACTIVE INGREDIENT83de9eef-aca5-449d-8365-a30c78652a2e8
INACTIVE INGREDIENTAmerisource Bergen Eye Itch Relief Drug Facts7
INACTIVE INGREDIENTDiabecline9
INACTIVE INGREDIENTOral Defense Fluoride Rinse12
INACTIVE INGREDIENT3 Step First Aid Kit Medication Filled Swabs11
INACTIVE INGREDIENT5678be04-5e19-4c87-8eca-5222b849660e10
INACTIVE INGREDIENTMethergine1000
INACTIVE INGREDIENTAspirin NSAIDS EC Tablet 325mg- 5gr9
INACTIVE INGREDIENTeb2b27ce-332a-48c1-9ae4-e2b5c2b11bb19
INACTIVE INGREDIENT3d15d591-76d5-454c-b491-3d2406710c4b8
INACTIVE INGREDIENT7c7431eb-93e0-4d79-a995-27edbdacfb469
INACTIVE INGREDIENTOral Defense Mouth Rinse17
INACTIVE INGREDIENTsilver sulfadiazine 1% cream3792
INACTIVE INGREDIENTBETAMETHASONE DIPROPIONATE CREAM USP, 0.05% BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% BETAMETHASONE DIPROPIONATE LOTION USP, 0.05%3706
INACTIVE INGREDIENTAmino Mask8
INACTIVE INGREDIENTDrug Facts7
INACTIVE INGREDIENTd02aec6b-b973-4e88-b42e-adb1ea7a607810
INACTIVE INGREDIENT37b694d8-8c23-4a4b-8919-70229bf3526e7
INACTIVE INGREDIENTa51fc004-9538-4e67-8f49-002babe17f9e9
INACTIVE INGREDIENTINFUVITE ® ADULT Multiple Vitamins for Infusion10
INACTIVE INGREDIENTThese highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone. Risperidone Oral Solution USP Initial U.S. Approval: 19939
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Medroxyprogesterone Acetate Injectable Suspension, USP safely and effectively. See full prescribing information for Medroxyprogesterone Acetate Injectable Suspension, USP. Medroxyprogesterone Acetate Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 19597
INACTIVE INGREDIENTDrug Facts9
INACTIVE INGREDIENTDrug Facts8
INACTIVE INGREDIENTDrug Facts12
INACTIVE INGREDIENTLeuprolide Acetate Injection13
INACTIVE INGREDIENTDRUG FACTS18
INACTIVE INGREDIENTDRUG FACTS13
INACTIVE INGREDIENTDRUG FACTS13
INACTIVE INGREDIENTDRUG FACTS7
INACTIVE INGREDIENTDrug Facts7
ACTIVE INGREDIENTSODIUM HYDROXIDE11
INACTIVE INGREDIENTFluorouracil Injection, USP11
INACTIVE INGREDIENTGENTAMICIN SULFATE SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPY DBA QUALITY CARE PRODUCTS LLC]3884
INACTIVE INGREDIENTLACTULOSE SOLUTION [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3880
INACTIVE INGREDIENTLIDOCAINE HYDROCHLORIDE SOLUTION [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3874
INACTIVE INGREDIENTNEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE) SUSPENSION [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3864
INACTIVE INGREDIENTPOLYMYXIN B SULFATE AND TRIMETHOPRIM (POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE) SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3852
INACTIVE INGREDIENTPATADAY (OLOPATADINE HYDROCHLORIDE) SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3728
INACTIVE INGREDIENTGENTAMICIN SULFATE SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3642
INACTIVE INGREDIENTERYTHROMYCIN BASE FILMTAB (ERYTHROMYCIN) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3641
INACTIVE INGREDIENTACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLIES DBA QUALITY CARE PRODUCTS LLC]3607
INACTIVE INGREDIENTARTHROTEC (DICLOFENAC SODIUM AND MISOPROSTOL) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3585
INACTIVE INGREDIENTACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUTCS LLC]3575
INACTIVE INGREDIENTOXYCONTIN (OXYCODONE HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3474
INACTIVE INGREDIENTNEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3473
INACTIVE INGREDIENTOXYCONTIN (OXYCODONE HYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3445
INACTIVE INGREDIENTTRANZGEL (ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, ACONITUM NAPELLUS, ARNICA MONTANA, CALENDULA OFFICIANALIS, HAMAMELIS VIRGINIANA, BELLADONNA, BELLIS PERENNIS, CHAMOMILLIA, MILLEFOLIUM, HYPERICUM PERFORATUM, SYMPHYTUM OFFICINALE, COLCHICINUM) GEL [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3162
INACTIVE INGREDIENTOXYCONTIN (OXYCODONE HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2101
INACTIVE INGREDIENTHUMIRA (ADALIMUMAB) KIT HUMIRA (ADALIMUMAB) INJECTION, SOLUTION [ABBVIE INC.]1805
INACTIVE INGREDIENTDEPACON (VALPROATE SODIUM) INJECTION [ABBVIE INC.]1531
INACTIVE INGREDIENTCALCIJEX (CALCITRIOL) INJECTION, SOLUTION [ABBVIE INC.]1415
INACTIVE INGREDIENTACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [BRYANT RANCH PREPACK]1001
INACTIVE INGREDIENTDICLOFENAC SODIUM AND MISOPROSTOL TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1001
INACTIVE INGREDIENTNEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1001
INACTIVE INGREDIENTPHENYLEPHRINE HYDROCHLORIDE SOLUTION [BRYANT RANCH PREPACK]1001
INACTIVE INGREDIENTDULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTDULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTNEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTNEUPOGEN (FILGRASTIM) INJECTION, SOLUTION [AMGEN INC]144
INACTIVE INGREDIENTNEULASTA (PEGFILGRASTIM) KIT NEULASTA (PEGFILGRASTIM) INJECTION [AMGEN INC]126
INACTIVE INGREDIENTANDROGEL (TESTOSTERONE) GEL [ABBVIE INC.]79
INACTIVE INGREDIENTANDROGEL (TESTOSTERONE) GEL [ABBVIE INC.]78
INACTIVE INGREDIENTABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
INACTIVE INGREDIENTHUMALOG (INSULIN LISPRO) INJECTION, SOLUTION HUMALOG KWIKPEN (INSULIN LISPRO) INJECTION, SOLUTION [ELI LILLY AND COMPANY]49
INACTIVE INGREDIENTZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]45
INACTIVE INGREDIENTALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY]43
INACTIVE INGREDIENTNEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE NEXIUM (ESOMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [ASTRAZENECA LP]41
INACTIVE INGREDIENTPROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]34
INACTIVE INGREDIENTOPTIRAY 350 (IOVERSOL) INJECTION OPTIRAY 320 (IOVERSOL) INJECTION OPTIRAY 300 (IOVERSOL) INJECTION OPTIRAY 240 (IOVERSOL) INJECTION [MALLINCKRODT INC.]33
INACTIVE INGREDIENTHUMALOG MIX50/50 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX50/50 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY]32
INACTIVE INGREDIENTHUMALOG MIX75/25 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX75/25 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY ]31
INACTIVE INGREDIENTPROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]31
INACTIVE INGREDIENTSUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
INACTIVE INGREDIENTOPTIMARK (GADOVERSETAMIDE) INJECTION, SOLUTION [MALLINCKRODT INC.]30
INACTIVE INGREDIENTPRILOSEC (OMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE PRILOSEC (OMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [ASTRAZENECA LP]29
INACTIVE INGREDIENTTYGACIL (TIGECYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]29
INACTIVE INGREDIENTROTATEQ (ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT) SOLUTION [MERCK SHARP & DOHME CORP.]27
INACTIVE INGREDIENTAVELOX (MOXIFLOXACIN HYDROCHLORIDE) INJECTION, SOLUTION AVELOX (MOXIFLOXACIN HYDROCHLORIDE) TABLET, FILM COATED [SCHERING PLOUGH CORPORATION]26
INACTIVE INGREDIENTCELLCEPT (MYCOPHENOLATE MOFETIL) TABLET, FILM COATED CELLCEPT (MYCOPHENOLATE MOFETIL) CAPSULE CELLCEPT (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION CELLCEPT (MYCOPHENOLATE MOFETIL) POWDER, FOR SUSPENSION [GENENTECH, INC.]26
INACTIVE INGREDIENTCUBICIN (DAPTOMYCIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.]26
INACTIVE INGREDIENTCLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION CLEOCIN PHOSPHATE (0009-6582) (STANDALONE) (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION [PHARMACIA AND UPJOHN COMPANY]25
INACTIVE INGREDIENTHUMATROPE (SOMATROPIN) KIT [ELI LILLY AND COMPANY]24
INACTIVE INGREDIENTACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [EISAI INC.]23
INACTIVE INGREDIENTFORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY]23
INACTIVE INGREDIENTINVANZ (ERTAPENEM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.]23

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 55X04QC32I page 1 of 3 · 174 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
SODIUM HYDROXIDE55X04QC32I1310732SOLUTIONAURICULAR (OTIC)0.8 %w/w
SODIUM HYDROXIDE55X04QC32I1310732SOLUTION/ DROPSAURICULAR (OTIC)ADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SUSPENSIONAURICULAR (OTIC)ADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SUSPENSION/ DROPSAURICULAR (OTIC)ADJ PH
SODIUM HYDROXIDE55X04QC32I1310732FILMBUCCAL0.09 mg
SODIUM HYDROXIDE55X04QC32I1310732FILM, SOLUBLEBUCCAL5 mg
SODIUM HYDROXIDE55X04QC32I1310732MOUTHWASHBUCCAL2 mg/1ml
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONDENTALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732PASTEDENTAL0.6 %w/w
SODIUM HYDROXIDE55X04QC32I1310732SOLUTIONDENTALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONENDOTRACHEALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732POWDER, FOR SUSPENSIONENDOTRACHEALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SUSPENSIONENDOTRACHEALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONEPIDURALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SOLUTIONEPIDURALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SOLUTIONEPIDURALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONEXTRACORPOREALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINFILTRATIONADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SOLUTIONINFILTRATIONADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTERSTITIALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRA-AMNIOTICADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRA-ARTERIAL176 mg
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, FOR SOLUTIONINTRA-ARTERIALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRA-ARTERIALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SOLUTIONINTRA-ARTERIALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SOLUTIONINTRA-ARTERIALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRA-ARTICULARADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SOLUTIONINTRA-ARTICULARADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SUSPENSIONINTRA-ARTICULARADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SUSPENSION, EXTENDED RELEASEINTRA-ARTICULARADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRABURSALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRACARDIACADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRACAUDALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SOLUTIONINTRACAUDALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRACAVERNOUSADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRACAVITARYADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRACAVITARYADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRADERMALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, FOR SOLUTIONINTRADERMALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SUSPENSION, EXTENDED RELEASEINTRADERMALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, FOR SOLUTIONINTRADISCALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRALESIONALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SUSPENSIONINTRALESIONALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SUSPENSION, EXTENDED RELEASEINTRALESIONALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRAMUSCULAR176 mg
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, FOR SOLUTIONINTRAMUSCULAR7.01 mg
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAMUSCULAR0.35 %w/v
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SOLUTIONINTRAMUSCULAR78 mg
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SUSPENSIONINTRAMUSCULARADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SUSPENSION, EXTENDED RELEASEINTRAMUSCULAR27 mg
SODIUM HYDROXIDE55X04QC32I1310732LIQUIDINTRAMUSCULARADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SOLUTIONINTRAMUSCULARADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SUSPENSION, EXTENDED RELEASEINTRAMUSCULAR5.4 mg
SODIUM HYDROXIDE55X04QC32I1310732SOLUTIONINTRAOCULARADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRAPERITONEALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SOLUTIONINTRAPERITONEALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRAPLEURALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRASPINALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRASYNOVIALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SUSPENSIONINTRASYNOVIALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SUSPENSION, EXTENDED RELEASEINTRASYNOVIALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRATHECAL176 mg
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, FOR SOLUTIONINTRATHECALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRATHECALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SOLUTIONINTRATHECALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SOLUTIONINTRATHECALADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRATUMORADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, FOR SOLUTIONINTRATUMORADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRAVASCULARADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SOLUTIONINTRAVASCULARADJ PH
SODIUM HYDROXIDE55X04QC32I1310732SOLUTIONINTRAVASCULARADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTABLE, LIPOSOMALINTRAVENOUSADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTIONINTRAVENOUS456 mg
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, EMULSIONINTRAVENOUSADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, FOR SOLUTIONINTRAVENOUS136.55 mg
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, FOR SUSPENSIONINTRAVENOUSADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAVENOUS78.36 mg
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SOLUTIONINTRAVENOUS78 mg
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SUSPENSIONINTRAVENOUSADJ PH
SODIUM HYDROXIDE55X04QC32I1310732INJECTION, SUSPENSION, LIPOSOMALINTRAVENOUSADJ PH